• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羟基甲基生物等排体的酚类 GluN2B 选择性 NMDA 受体拮抗剂:设计、合成和药理学评价。

Hydroxymethyl bioisosteres of phenolic GluN2B-selective NMDA receptor antagonists: Design, synthesis and pharmacological evaluation.

机构信息

Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Corrensstraße 48, D-48149 Münster, Germany; Cells-in-Motion Cluster of Excellence (EXC 1003-CiM), Westfälische Wilhelms-Universität Münster, Germany.

Institut für Pharmazeutische und Medizinische Chemie der Universität Münster, Corrensstraße 48, D-48149 Münster, Germany.

出版信息

Eur J Med Chem. 2018 Jan 20;144:672-681. doi: 10.1016/j.ejmech.2017.12.054. Epub 2017 Dec 18.

DOI:10.1016/j.ejmech.2017.12.054
PMID:29289890
Abstract

Antagonists addressing selectively NMDA receptors containing the GluN2B subunit are of particular interest for the treatment of various neurological disorders including neurodegenerative diseases. With the aim to bioisosterically replace the metabolically labile phenol of 7-amino-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-ols, several analogs were docked into the ifenprodil binding site leading to the hydroxymethyl derivatives 4 as promising candidates. They display the same binding pose as Ro 25-6981 and the same H-bond interactions with Gln110 and Glu236 within the GluN2B subunit. The phenylalkyl moieties occupy the hydrophobic pocket formed predominantly by Pro78 (GluN2B), Phe114 (GluN2B), and Tyr109 (GluN1b). Starting from o-phthalaldehyde, the hydroxymethyl derivatives 4 were prepared in a 7-step synthesis with a haloform reaction of trichloroacetophenone 7 as key step. In receptor binding studies, the phenylpropyl derivative 4a shows promising GluN2B affinity (K = 101 nM) and high selectivity over the PCP binding site and both σ receptor subtypes. 4a was able to inhibit the glutamate/glycine induced cytotoxicity at mouse fibroblasts with an IC value of 5.2 μM. It is assumed that the hydroxymethyl moiety of 4a stabilizes the closed channel conformation by an H-bond with Glu236 as does the phenolic OH moiety of 3, Ro 25-6981 and ifenprodil.

摘要

选择性作用于包含 GluN2B 亚基的 NMDA 受体的拮抗剂特别适合治疗各种神经紊乱,包括神经退行性疾病。为了生物等排取代 7-氨基-6,7,8,9-四氢-5H-苯并[7]环庚烯-2-醇中代谢不稳定的酚,将几种类似物对接进入ifenprodil 结合位点,得到了具有前景的羟甲基衍生物 4。它们与 Ro 25-6981 具有相同的结合构象,与 GluN2B 亚基中的 Gln110 和 Glu236 具有相同的氢键相互作用。苯烷基部分占据由 Pro78 (GluN2B)、Phe114 (GluN2B)和 Tyr109 (GluN1b) 主要形成的疏水性口袋。以邻苯二醛为起始原料,通过三氯乙酮 7 的卤仿反应作为关键步骤,经 7 步合成得到了羟甲基衍生物 4。在受体结合研究中,苯基丙基衍生物 4a 表现出良好的 GluN2B 亲和力(K = 101 nM),对 PCP 结合位点和两种 σ 受体亚型具有高选择性。4a 能够抑制谷氨酸/甘氨酸诱导的小鼠成纤维细胞细胞毒性,IC 值为 5.2 µM。假设 4a 的羟甲基部分通过与 Glu236 的氢键稳定了闭合通道构象,就像 3、Ro 25-6981 和 ifenprodil 的酚羟基部分一样。

相似文献

1
Hydroxymethyl bioisosteres of phenolic GluN2B-selective NMDA receptor antagonists: Design, synthesis and pharmacological evaluation.羟基甲基生物等排体的酚类 GluN2B 选择性 NMDA 受体拮抗剂:设计、合成和药理学评价。
Eur J Med Chem. 2018 Jan 20;144:672-681. doi: 10.1016/j.ejmech.2017.12.054. Epub 2017 Dec 18.
2
Design, Synthesis, Pharmacological Evaluation and Docking Studies of GluN2B-Selective NMDA Receptor Antagonists with a Benzo[7]annulen-7-amine Scaffold.基于苯并[7]环壬烯-7-胺骨架的GluN2B选择性NMDA受体拮抗剂的设计、合成、药理学评价及对接研究
ChemMedChem. 2017 Aug 8;12(15):1212-1222. doi: 10.1002/cmdc.201700311. Epub 2017 Jul 27.
3
GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists derived from 3-benzazepines: synthesis and pharmacological evaluation of benzo[7]annulen-7-amines.3-苯氮杂卓衍生的 GluN2B 选择性 N-甲基-D-天冬氨酸(NMDA)受体拮抗剂:苯并[7]氮杂环庚-7-胺的合成与药理学评价。
ChemMedChem. 2014 Apr;9(4):741-51. doi: 10.1002/cmdc.201300547. Epub 2014 Feb 23.
4
2-Methyltetrahydro-3-benzazepin-1-ols - The missing link in SAR of GluN2B selective NMDA receptor antagonists.2-甲基四氢-3-苯并氮杂卓-1-醇——谷氨酸N2B亚基选择性N-甲基-D-天冬氨酸受体拮抗剂构效关系中缺失的环节。
Bioorg Med Chem. 2018 Jan 15;26(2):501-508. doi: 10.1016/j.bmc.2017.12.010. Epub 2017 Dec 7.
5
Thiophene bioisosteres of GluN2B selective NMDA receptor antagonists: Synthesis and pharmacological evaluation of [7]annuleno[b]thiophen-6-amines.噻吩类 GluN2B 选择性 NMDA 受体拮抗剂的生物等排体:[7]并苯并[b]噻吩-6-胺的合成与药理学评价。
Bioorg Med Chem. 2020 Jan 15;28(2):115245. doi: 10.1016/j.bmc.2019.115245. Epub 2019 Dec 9.
6
Deconstruction - Reconstruction: Analysis of the Crucial Structural Elements of GluN2B-Selective, Negative Allosteric NMDA Receptor Modulators with 3-Benzazepine Scaffold.去构筑-再构筑:含 3-苯并氮䓬骨架的 GluN2B 选择性负变构型 NMDA 受体调节剂关键结构要素分析。
Cell Physiol Biochem. 2021 Mar 3;55(S3):1-13. doi: 10.33594/000000335.
7
Deconstruction - reconstruction approach to analyze the essential structural elements of tetrahydro-3-benzazepine-based antagonists of GluN2B subunit containing NMDA receptors.解构-重构方法分析含NMDA受体GluN2B亚基的四氢-3-苯并氮杂卓类拮抗剂的基本结构要素。
Eur J Med Chem. 2017 Sep 29;138:552-564. doi: 10.1016/j.ejmech.2017.06.068. Epub 2017 Jul 1.
8
Synthesis, GluN2B affinity and selectivity of benzo[7]annulen-7-amines.苯并[7]环壬烯-7-胺的合成、GluN2B亲和力和选择性
Bioorg Med Chem. 2014 Dec 1;22(23):6638-6646. doi: 10.1016/j.bmc.2014.10.004. Epub 2014 Oct 12.
9
Pyridine bioisosteres of potent GluN2B subunit containing NMDA receptor antagonists with benzo[7]annulene scaffold.具有苯并[7]轮烯骨架的强 GluN2B 亚基含 NMDA 受体拮抗剂的吡啶生物等排体。
Eur J Med Chem. 2018 Sep 5;157:397-404. doi: 10.1016/j.ejmech.2018.08.003. Epub 2018 Aug 4.
10
Negative allosteric modulators of the GluN2B NMDA receptor with phenylethylamine structure embedded in ring-expanded and ring-contracted scaffolds.在环扩和环缩骨架中嵌入苯乙胺结构的 GluN2B NMDA 受体的负变构调节剂。
Eur J Med Chem. 2020 Mar 15;190:112138. doi: 10.1016/j.ejmech.2020.112138. Epub 2020 Feb 10.

引用本文的文献

1
Phenol (bio)isosteres in drug design and development.药物设计与开发中的苯酚(生物)电子等排体
Arch Pharm (Weinheim). 2025 Jan;358(1):e2400700. doi: 10.1002/ardp.202400700. Epub 2024 Nov 24.
2
GluN2B subunit selective N-methyl-D-aspartate receptor ligands: Democratizing recent progress to assist the development of novel neurotherapeutics.GluN2B 亚单位选择性 N-甲基-D-天冬氨酸受体配体:推进最新进展,以帮助开发新型神经治疗药物。
Mol Divers. 2024 Jun;28(3):1765-1792. doi: 10.1007/s11030-023-10656-0. Epub 2023 Jun 2.
3
Drug/Lead Compound Hydroxymethylation as a Simple Approach to Enhance Pharmacodynamic and Pharmacokinetic Properties.
药物/先导化合物羟甲基化:一种增强药效学和药代动力学性质的简单方法
Front Chem. 2022 Feb 14;9:734983. doi: 10.3389/fchem.2021.734983. eCollection 2021.
4
[2.2]Paracyclophane-Based TCN-201 Analogs as GluN2A-Selective NMDA Receptor Antagonists.[2.2]基于对环芳烷的 TCN-201 类似物作为 GluN2A 选择性 NMDA 受体拮抗剂。
ChemMedChem. 2021 Oct 15;16(20):3201-3209. doi: 10.1002/cmdc.202100400. Epub 2021 Aug 3.